Phio Pharmaceuticals Corp. (PHIO)
1.17
-0.01
(-0.85%)
USD |
NASDAQ |
Aug 24, 16:00
1.15
-0.02
(-1.71%)
After-Hours: 20:00
Phio Pharmaceuticals Total Assets (Quarterly) : 14.31M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.31M |
| March 31, 2026 | 17.41M |
| December 31, 2025 | 21.49M |
| September 30, 2025 | 11.50M |
| June 30, 2025 | 11.30M |
| March 31, 2025 | 13.44M |
| December 31, 2024 | 5.738M |
| September 30, 2024 | 5.865M |
| June 30, 2024 | 5.296M |
| March 31, 2024 | 6.853M |
| December 31, 2023 | 9.364M |
| September 30, 2023 | 9.539M |
| June 30, 2023 | 12.30M |
| March 31, 2023 | 9.707M |
| December 31, 2022 | 12.81M |
| September 30, 2022 | 15.79M |
| June 30, 2022 | 20.14M |
| March 31, 2022 | 22.16M |
| December 31, 2021 | 25.17M |
| September 30, 2021 | 27.94M |
| June 30, 2021 | 31.66M |
| March 31, 2021 | 33.86M |
| December 31, 2020 | 15.74M |
| September 30, 2020 | 18.24M |
| June 30, 2020 | 20.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.30M |
| December 31, 2019 | 8.039M |
| September 30, 2019 | 10.08M |
| June 30, 2019 | 12.11M |
| March 31, 2019 | 13.68M |
| December 31, 2018 | 15.32M |
| September 30, 2018 | 3.809M |
| June 30, 2018 | 6.031M |
| March 31, 2018 | 3.09M |
| December 31, 2017 | 4.098M |
| September 30, 2017 | 6.033M |
| June 30, 2017 | 8.391M |
| March 31, 2017 | 10.51M |
| December 31, 2016 | 13.40M |
| September 30, 2016 | 4.901M |
| June 30, 2016 | 6.521M |
| March 31, 2016 | 8.174M |
| December 31, 2015 | 11.16M |
| September 30, 2015 | 12.70M |
| June 30, 2015 | 14.95M |
| March 31, 2015 | 7.169M |
| December 31, 2014 | 9.189M |
| September 30, 2014 | 10.90M |
| June 30, 2014 | 12.55M |
| March 31, 2014 | 12.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Imunon, Inc. | 14.99M |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.705M |
| Shareholders Equity (Quarterly) | 12.60M |
| Current Ratio | 8.386 |